Currently, there are 37.79M common shares owned by the public and among those 32.16M shares have been available to trade.
The company’s stock has a 5-day price change of 47.66% and 12.86% over the past three months. APYX shares are trading 0.00% year to date (YTD), with the 12-month market performance down to -4.82% lower. It has a 12-month low price of $0.76 and touched a high of $1.95 over the same period. APYX has an average intraday trading volume of 52.10K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 48.69%, 42.81%, and 21.54% respectively.
Institutional ownership of Apyx Medical Corp (NASDAQ: APYX) shares accounts for 41.59% of the company’s 37.79M shares outstanding.
It has a market capitalization of $59.71M and a beta (3y monthly) value of 1.05. The earnings-per-share (ttm) stands at -$0.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 19.23% over the week and 14.33% over the month.
Earnings per share for the fiscal year are expected to increase by 40.33%, and -3.75% over the next financial year. EPS should grow at an annualized rate of 20.65% over the next five years, compared to -2.68% over the past 5-year period.
Stephens coverage for the Apyx Medical Corp (APYX) stock in a research note released on July 14, 2023 offered a Overweight rating with a price target of $8. Lake Street was of a view on May 20, 2022 that the stock is Buy, while Dougherty & Company gave the stock Buy rating on April 02, 2019, issuing a price target of $12- $9.
